namita thapar to gain ₹127.8 cr from emcure pharma ipo
Published 1 month ago • 1.5K plays • Length 0:59
Download video MP4
Download video MP3
Similar videos
-
1:14
namita thapar-backed emcure pharma ipo to fetch her 127 cr on exit
-
0:48
namita thapar's emcure pharma ipo opens: should you bid? | ipo #shorts
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
0:43
namita thapar's emcure pharma makes bumper #stockmarket debut, lists at 31% premium on nse
-
25:46
namita thapar-backed emcure pharma’s rs 1,952 cr ipo opens|management on post-ipo roadmap| ipo watch
-
26:37
buy natco pharma, finolex cables: gaurang shah
-
1:58
namita thapar on women taking the lead as entrepreneurs
-
16:35
top 2 pharma midcap stocks | ca rachana ranade
-
19:30
will you invest in shark tank's namita thapar's company. emcure pharma ipo to open on july 3rd
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
4:34
top 10 things to know about emcure pharmaceuticals ipo | namita thapar's emcure pharma ipo review
-
2:26
‘shark’ namita thapar’s investment swells 38,200% after strong emcure pharma listing! | details
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
4:17
emcure pharmaceuticals ipo review | issue details, financials, products | namita thapar | must watch
-
5:08
emcure pharma ipo: namita thappar on tie up with sanofi & in-house products for cardiac segment
-
3:45
emcure pharma ipo open for subscription today, all you need to know! | investors & valuation |et now
-
3:34
✅ akums drugs & pharmaceuticals ipo gmp today | akums gmp analysis kitna listing gain
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
-
17:12
namita thapar's emcure pharma ipo - apply or avoid? expected listing gain? vibhor varshney
-
2:31
tomorrow inc: emcure heiress namita thapar on women entrepreneurs taking the helm
-
7:44
emcure pharma ipo to open next week, rationale behind the fundraise & utilization plans | et now
-
0:59
emcure pharma lists at 31% premium over ipo price, management to focus on emerging markets
Clip.africa.com - Privacy-policy